Acquisition - Schedule of Assets Acquired and Liabilities Assumed (Details) - USD ($)	Jul. 15, 2019	Sep. 30, 2019	Dec. 31, 2018
Business Acquisition [Line Items]
Total acquired identifiable intangible assets	$ 7,300,000	$ 7,600,000
Goodwill	8,300,000	$ 8,273,000
BioPharma Acquisition [Member]
Business Acquisition [Line Items]
Cash	13,829,000
Subordinated note payable	6,822,000
Total consideration	20,651,000
Accounts receivable	3,731,000
Accrued revenue	289,000
Lab supplies	877,000
Prepaid expenses	266,000
Property and equipment	6,412,000
Operating lease assets	2,187,000
Total acquired identifiable intangible assets	7,300,000
Goodwill	8,273,000
Total assets acquired	29,335,000
Accounts payable	(4,535,000)
Accrued liabilities	(435,000)
Deferred revenue	(1,076,000)
Operating lease liabilities	(2,187,000)
Finance lease liabilities	(451,000)
Total liabilities assumed	(8,684,000)
Net assets acquired	20,651,000
BioPharma Acquisition [Member] | Trademarks and Trade Name [Member]
Business Acquisition [Line Items]
Total acquired identifiable intangible assets	1,600,000
BioPharma Acquisition [Member] | Customer Relationships [Member]
Business Acquisition [Line Items]
Total acquired identifiable intangible assets	$ 5,700,000